10.1016/j.csbj.2018.06.002
10.1016/j.csbj.2018.06.002 · doi-reference
PBPK modeling and simulation in drug research and development
10.1016/j.apsb.2016.04.004 · doi-reference
10.1093/nar/gkz240
10.1093/nar/gkz240 · doi-reference
A comprehensive overview and critical evaluation of gene regulatory network inference technologies
10.1093/bib/bbab009 · doi-reference
GeNeCK: a web server for gene network construction and visualization
10.1186/s12859-018-2560-0 · doi-reference
A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer
10.1016/j.csbj.2022.11.037 · doi-reference
10.1124/pr.120.019554
10.1124/pr.120.019554 · doi-reference
10.1038/s41576-021-00389-x
10.1038/s41576-021-00389-x · doi-reference
PK-Sim®: a physiologically based pharmacokinetic ‘whole-body’ model
10.1016/s1478-5382(03)02342-4 · doi-reference
10.1038/35066048
10.1038/35066048 · doi-reference
10.1016/j.jtbi.2022.111055
10.1016/j.jtbi.2022.111055 · doi-reference
10.1016/j.csbj.2020.10.022
10.1016/j.csbj.2020.10.022 · doi-reference
Characterization of the synthetic biology-inspired implementation of a materials-based positive feedback loop
10.1016/j.dib.2018.05.074 · doi-reference
A review of mathematical and computational methods in cancer dynamics
10.3389/fonc.2022.850731 · doi-reference
10.1016/j.jtbi.2018.11.034
10.1016/j.jtbi.2018.11.034 · doi-reference
10.1016/j.tcb.2020.04.002
10.1016/j.tcb.2020.04.002 · doi-reference
Autophagy regulatory network—a systems-level bioinformatics resource for studying the mechanism and regulation of autophagy
10.4161/15548627.2014.994346 · doi-reference
10.1002/pro.3307
10.1002/pro.3307 · doi-reference
10.1093/nar/gkx247
10.1093/nar/gkx247 · doi-reference
10.1007/978-3-319-28095-0
10.1007/978-3-319-28095-0 · doi-reference
Structure identifiability in metabolic pathways: parameter estimation in models based on the power-law formalism
10.1042/bj2980303 · doi-reference
Model-based analysis of interferon-beta induced signaling pathway
10.1093/bioinformatics/btn400 · doi-reference
Coupled analytical and numerical approach to uncovering new regulatory mechanisms of intracellular processes
10.2478/v10006-010-0060-0 · doi-reference
Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective
10.1002/cpt.1013 · doi-reference
Network-based drug repurposing: a critical review
10.2174/2589977514666220214120403 · doi-reference
10.1007/10_2020_158
10.1007/10_2020_158 · doi-reference
10.1016/j.csbj.2020.03.001
10.1016/j.csbj.2020.03.001 · doi-reference
Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121)
10.1038/npjsba.2016.34 · doi-reference
10.1126/scisignal.2000352
10.1126/scisignal.2000352 · doi-reference
To what extent can mathematical modeling inform the design of clinical trials? The example of safe dose reduction of tyrosine kinase inhibitors in responding patients with chronic myeloid leukemia
10.3324/haematol.2018.201897 · doi-reference
Quantitative characterization of genetic parts and circuits for plant synthetic biology
10.1038/nmeth.3659 · doi-reference
10.1073/pnas.1913773116
10.1073/pnas.1913773116 · doi-reference
A web tool for consensus gene regulatory network construction
10.3389/fgene.2021.745827 · doi-reference
10.1016/j.mib.2020.02.008
10.1016/j.mib.2020.02.008 · doi-reference
Epirubicin/docetaxel regimen in progressive breast cancer-a phase II study
10.1097/00001813-200210000-00004 · doi-reference
10.1016/j.csbj.2021.08.028
10.1016/j.csbj.2021.08.028 · doi-reference
10.1038/nrd.2016.246
10.1038/nrd.2016.246 · doi-reference
10.1182/blood-2013-02-483750
10.1182/blood-2013-02-483750 · doi-reference
10.1016/j.jtbi.2018.11.028
10.1016/j.jtbi.2018.11.028 · doi-reference
10.1017/cbo9780511625268
10.1017/cbo9780511625268 · doi-reference
